| (Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
| Sales | 19,240 | 15,560 | 13,860 | 7,580 | 3,840 |
| Sales Growth | +23.65% | +12.27% | +82.85% | +97.40% | +57.38% |
| Net Income | -8,150 | -10,720 | -10,370 | -11,560 | -10,710 |
| Net Income Growth | +23.97% | -3.38% | +10.29% | -7.94% | -3.78% |
Myomo Inc (MYO)
5.29 -0.14 (-2.58%) 09:51 ET [NYSE Arca]
5.28 x 1 5.36 x 100
Realtime by (Cboe BZX)
5.28 x 1 5.36 x 100
Realtime 5.81 +0.38 (+7.00%) 09:25 ET
for Thu, Mar 13th, 2025
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.
Fiscal Year End Date: 12/31